Browse L-dopa topic

Subtopics (13)

Articles

1-27 out of 27 article(s)

Title	Author	Type	Date	Words
Depomed Reports Encouraging Results of its Phase I Trial for DM-1992 Program in Parkinson's Disease.			Aug 10, 2009	941
IMPAX to Develop Next-Generation Carbidopa/Levodopa Product.			Apr 14, 2008	626
Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S. Food and Drug Administration for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease.			Feb 18, 2008	709
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options.			Jan 30, 2008	610
Adding safinamide to dopamine agonists eases Parkinson's.	Schonfeld, Amy Rothman		Aug 1, 2007	399
IMPAX Presents at Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders.			Jun 8, 2007	830
NeuroDerm's Transdermal L-DOPA Parkinson's Patch Completes First Clinical Trial.			Jan 31, 2007	379
Chronic tics did not worsen for patients on levodopa.	Brunk, Doug	Statistical data	Jul 1, 2006	433
CreAgri, DSM join forces.		Brief article	May 1, 2006	96
Treating parkinsonism in HIV-positive patients can spur infection, psychosis.	Wachter, Kerri	Statistical data	Apr 1, 2006	339
Low-protein diet boosts treatment.		Brief article	Mar 11, 2006	313
Human retinal cells implanted into Parkinson's patients brains improve motor symptoms.		Brief Article	Feb 13, 2006	177
Levodopa and the progression of Parkinson's disease.		Brief Article	Mar 1, 2005	238
Rapid-dissolving Parkinson's drug.		Brief Article	Oct 1, 2004	46
Early levodopa seems to slow Parkinson's. (9-Month Randomized Trial).	Finn, Robert		May 1, 2003	429
Parkinson's drugs could put patients at risk.			Mar 22, 2003	584
Pallidotomy for Parkinson's spurred hypersexuality. (Case Report).	Finn, Robert	Brief Article	May 1, 2002	398
Selected abstracts. (*) (Special Feature).		Statistical Data Included	Dec 1, 2001	1806
Two drugs may enhance recovery from stroke.	Seppa, N.	Brief Article	Sep 15, 2001	532
An alternate approach to Parkinson's.	N.S.	Brief Article	Jun 10, 2000	264
PHYSIOLOGICAL COST INDEX AS AN INDICATOR OF THE EFFECTS OF LEVODOPA THERAPY IN PATIENTS WITH PARKINSON DISEASE.	Yeh, SI		May 1, 2000	20
Tolcapone Tablets (Tasmar-Roche Pharmaceuticals).			Jan 1, 1999	1320
Variability in spatiotemporal gait characteristics over the course of the L-dopa cycle in people with advanced Parkinson disease.	MacKay-Lyons, Marilyn		Oct 1, 1998	6103
Free-radical toxicity and antioxidant medications in Parkinson's disease.	Ciccone, Charles D.		Mar 1, 1998	4108
First Parkinson's drug FDA-approved since 1989.			Sep 1, 1997	703
New drug offers alternative Parkinson's treatment.			Jul 1, 1997	443
Silk, glue proteins in worm's cement.		Brief Article	Jul 25, 1992	217

Browse  L-dopa topic

Subtopics (13)

Articles

Browse L-dopa topic